News
Astellas, Seagen seek speedy reviews of Padcev in bladder ca...
The next milestone in Seagen and Astellas' bid to build their antibody-drug conjugate (ADC) Padcev into a blockbuster will come in August, when the FDA concludes an accelerated review of tw
